37 286

Cited 10 times in

Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in a Behcet's disease mouse model.

Authors
Bang, D; Choi, B; Kwon, HJ; Lee, ES; Lee, S; Sohn, S
Citation
European journal of pharmacology, 598(1-3):112-117, 2008
Journal Title
European journal of pharmacology
ISSN
0014-29991879-0712
Abstract
Rebamipide inhibits free radicals derived from activated neutrophils and decreases the inhibiting inflammatory cytokine. Behcet's disease (BD) is a chronic, multi-systemic inflammatory disorder with arthritic, gastrointestinal, mucocutaneous, ocular, vascular, and central nervous system involvement. This disease has a chronic course with periodic exacerbations and progressive deterioration. To study the effect of rebamipide treatment to BD-like mice, combination treatment with rebamipide and colchicine was compared to colchicine treatment. Colchicine is one of the most frequently prescribed medicine to the patients with BD. For each BD mouse, 200 microl gastric fluid or 2 microg colchicine or 150 microg rebamipide or 2 microg colchicine plus 150 microg rebamipide was treated orally once per day. Treatment was done for 5 consecutive days. Two hour or 20 days after last administration, spleens were isolated for RT-PCR and real time PCR, and serum was collected for ELISA. In the combination treated group, TNF alpha, MIP-1 alpha, p22 phox, p47 phox, and gp91 phox mRNA expressions were lower than rebamipide treated or colchicine treated groups by reverse transcriptase PCR. NADPH oxidase subunits mRNA were markedly downregulated compared to the colchicine treated group by real time PCR. At 20 days after administration, combination treatment decreased 23.5% of the severity score compared to before administration. In contrast, colchicine treatment decreased 14.3% of the severity score compared to before administration. Rebamipide helped the function of colchicine to improve the HSV induced BD-like symptoms by inhibiting the expression of NADPH oxidase in vivo mouse model.
MeSH terms
Alanine/analogs & derivatives*Alanine/pharmacologyAnimalsAnti-Inflammatory Agents, Non-Steroidal*Behcet Syndrome/drug therapy*Behcet Syndrome/pathologyColchicine/therapeutic use*Enzyme-Linked Immunosorbent AssayHerpes Simplex/drug therapy*Herpes Simplex/pathologyInflammation/drug therapy*Inflammation/pathologyMaleMiceMice, Inbred ICRNADPH Oxidase/metabolismQuinolones/pharmacology*RNA, Messenger/biosynthesisvRNA, Messenger/geneticsReverse Transcriptase Polymerase Chain ReactionTubulin Modulators/therapeutic use*
DOI
10.1016/j.ejphar.2008.09.005
PMID
18823974
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Dermatology
Journal Papers > School of Medicine / Graduate School of Medicine > Microbiology
AJOU Authors
이은소손성향
Full Text Link
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse